• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL UNKNOWN TISSUE HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL UNKNOWN TISSUE HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number UNK TISSUE HEART VALVE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/01/2001
Event Type  Death  
Manufacturer Narrative
Summarized patient outcomes/complications of surgical aortic valve replacement (savr) to validate the roles of prosthesis-patient mismatch (ppm) and valve size were reported in a research article ¿association of valve size and hemodynamic performance with clinical outcomes in aortic valve replacement¿, in a subject population with multiple co-morbidities including smoking, aortic stenosis, aortic regurgitation, mitral regurgitation, tricuspid regurgitation, hypertension, diabetes, hyperlipidemia, coronary arterial disease, atrial fibrillation, chronic obstructive pulmonary disease, liver cirrhosis, chronic kidney disease, infective endocarditis, rheumatic heart disease, gout, malignancy, prior stroke, prior myocardial infarction, gastrointestinal bleeding, intracranial hemorrhage, major bleeding event, heart failure hospitalization.Some of the complications reported were death, redo aortic valve repair (surgical intervention), all-cause readmission (hospitalization), infective endocarditis, heart failure, aortic stenosis; these complications are anticipated for the procedure and subject population.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device or individual patient information was received for analysisna.
 
Event Description
The article, ¿association of valve size and hemodynamic performance with clinical outcomes in aortic valve replacement¿, was reviewed.The article presented a retrospective, single center study analyzing a large asian cohort with long-term follow-up hemodynamic and clinical outcome data after surgical aortic valve replacement (savr) to validate the roles of prosthesis-patient mismatch (ppm) and valve size.Devices included in this study were hancock ii, st jude epic, sav, trifecta, mosaic, magna ease/perimount, and unknown.The article concluded that relative to those receiving larger valves, patients receiving small bioprosthetic valves had poorer hemodynamic performance but did not demonstrate differences in clinical events in long-term follow-up.[the primary and corresponding author was shao-wei chen, chang gung memorial hospital, linkou medical center, chang gung university, no.5 fuxing street, guishan district, taoyuan city 33305, taiwan, with corresponding email: josephchen0314@gmail.Com].The time frame of the study was from 01 january 2001 to 31 december 2018.A total of 695 patients were included in the study, of which 390 (56.2%) received an abbott device.The average age was 66.8 years, the average weight was 62.0 kg, and the average gender was male.Comorbidities included smoking, aortic stenosis, aortic regurgitation, mitral regurgitation, tricuspid regurgitation, hypertension, diabetes, hyperlipidemia, coronary arterial disease, atrial fibrillation, chronic obstructive pulmonary disease, liver cirrhosis, chronic kidney disease, infective endocarditis, rheumatic heart disease, gout, malignancy, prior stroke, prior myocardial infarction, gastrointestinal bleeding, intracranial hemorrhage, major bleeding event, heart failure hospitalization.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN TISSUE HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG#3007113487
177 county road b east
st. paul MN 55117 1789
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18691734
MDR Text Key335184689
Report Number2135147-2024-00623
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeTW
PMA/PMN Number
P040021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 02/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/12/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK TISSUE HEART VALVE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/30/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-